Drel VR - Search Results

1

Centrality of bone marrow in the severity of gadolinium-based contrast-induced systemic fibrosis.

Drel VR, Tan C, Barnes JL, Gorin Y, Lee DY, Wagner B. Drel VR, et al. FASEB J. 2016 Sep;30(9):3026-38. doi: 10.1096/fj.201500188R. Epub 2016 May 24. FASEB J. 2016. PMID: 27221979 Free PMC article.

2

Pathophysiology of gadolinium-associated systemic fibrosis.

Wagner B, Drel V, Gorin Y. Wagner B, et al. Am J Physiol Renal Physiol. 2016 Jul 1;311(1):F1-F11. doi: 10.1152/ajprenal.00166.2016. Epub 2016 May 4. Am J Physiol Renal Physiol. 2016. PMID: 27147669 Free PMC article. Review.

3

Nephrogenic Systemic Fibrosis Is Mediated by Myeloid C-C Chemokine Receptor 2.

Do C, Drel V, Tan C, Lee D, Wagner B. Do C, et al. J Invest Dermatol. 2019 Oct;139(10):2134-2143.e2. doi: 10.1016/j.jid.2019.03.1145. Epub 2019 Apr 9. J Invest Dermatol. 2019. PMID: 30978353 Free PMC article.

4

Female Protection Against Diabetic Kidney Disease Is Regulated by Kidney-Specific AMPK Activity.

Lee HJ, Min L, Gao J, Matta S, Drel V, Saliba A, Tamayo I, Montellano R, Hejazi L, Maity S, Xu G, Grajeda BI, Roy S, Hallows KR, Choudhury GG, Kasinath BS, Sharma K. Lee HJ, et al. Diabetes. 2024 Jul 1;73(7):1167-1177. doi: 10.2337/db23-0807. Diabetes. 2024. PMID: 38656940

5

PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function.

Lupachyk S, Shevalye H, Maksimchyk Y, Drel VR, Obrosova IG. Lupachyk S, et al. Among authors: drel vr. Free Radic Biol Med. 2011 May 15;50(10):1400-9. doi: 10.1016/j.freeradbiomed.2011.01.037. Epub 2011 Feb 24. Free Radic Biol Med. 2011. PMID: 21300148 Free PMC article.

6

A technology assisted precision ketogenic diet intervention for cardio-renal-metabolic health in overweight or obese adults: Protocol for a randomized controlled trial.

Du Y, Wang J, Li S, Dennis B, Meireles C, Siddiqui N, Patel D, Gelfond J, Li C, Faruqui SH, Alaeddini A, Drel V, Tumova J, Ye H, Montellano R, Armaiz-Pena G, Sharma K. Du Y, et al. Contemp Clin Trials. 2022 Aug;119:106845. doi: 10.1016/j.cct.2022.106845. Epub 2022 Jul 7. Contemp Clin Trials. 2022. PMID: 35809772

7

Low-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy.

Li F, Drel VR, Szabó C, Stevens MJ, Obrosova IG. Li F, et al. Among authors: drel vr. Diabetes. 2005 May;54(5):1514-22. doi: 10.2337/diabetes.54.5.1514. Diabetes. 2005. PMID: 15855340

8

Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.

Obrosova IG, Drel VR, Pacher P, Ilnytska O, Wang ZQ, Stevens MJ, Yorek MA. Obrosova IG, et al. Among authors: drel vr. Diabetes. 2005 Dec;54(12):3435-41. doi: 10.2337/diabetes.54.12.3435. Diabetes. 2005. PMID: 16306359 Free PMC article.

9

Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells.

Drel VR, Pacher P, Stevens MJ, Obrosova IG. Drel VR, et al. Free Radic Biol Med. 2006 Apr 15;40(8):1454-65. doi: 10.1016/j.freeradbiomed.2005.12.034. Epub 2006 Jan 31. Free Radic Biol Med. 2006. PMID: 16631535 Free PMC article.

10

Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.

Ilnytska O, Lyzogubov VV, Stevens MJ, Drel VR, Mashtalir N, Pacher P, Yorek MA, Obrosova IG. Ilnytska O, et al. Among authors: drel vr. Diabetes. 2006 Jun;55(6):1686-94. doi: 10.2337/db06-0067. Diabetes. 2006. PMID: 16731831 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters